Total Payments
$8,522
2021 Payments
$313.88
Companies
28
Transactions
226
Medicare Patients
329
Medicare Billing
$22,701
Payment Breakdown by Category
Food & Beverage$3,295 (38.7%)
Consulting$2,250 (26.4%)
Travel$1,531 (18.0%)
Research$1,197 (14.0%)
Other$250.00 (2.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,295 | 204 | 38.7% |
| Consulting Fee | $2,250 | 1 | 26.4% |
| Travel and Lodging | $1,531 | 2 | 18.0% |
| Unspecified | $1,197 | 18 | 14.0% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $250.00 | 1 | 2.9% |
Payments by Type
General
$7,325
208 transactions
Research
$1,197
18 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Corcept Therapeutics | $4,278 | 12 | $0 (2019) |
| Gilead Sciences, Inc. | $1,197 | 18 | $0 (2019) |
| Novo Nordisk Inc | $466.85 | 37 | $0 (2020) |
| Tandem Diabetes Care, Inc. | $358.01 | 7 | $0 (2021) |
| AstraZeneca Pharmaceuticals LP | $314.67 | 20 | $0 (2021) |
| Amgen Inc. | $290.53 | 16 | $0 (2020) |
| Insulet Corporation | $262.81 | 26 | $0 (2019) |
| DEXCOM, INC. | $250.48 | 15 | $0 (2021) |
| Lilly USA, LLC | $217.66 | 15 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $168.07 | 14 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $313.88 | 18 | AstraZeneca Pharmaceuticals LP ($53.95) |
| 2020 | $393.12 | 27 | AstraZeneca Pharmaceuticals LP ($81.86) |
| 2019 | $6,593 | 93 | Corcept Therapeutics ($4,215) |
| 2018 | $852.97 | 60 | Novo Nordisk Inc ($225.83) |
| 2017 | $369.64 | 28 | Lilly USA, LLC ($64.67) |
All Payment Transactions
226 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/13/2021 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 07/01/2021 | AbbVie Inc. | — | Food and Beverage | In-kind items and services | $15.11 | General |
| 06/24/2021 | Tandem Diabetes Care, Inc. | t-slim insulin pump (Device) | Food and Beverage | Cash or cash equivalent | $23.93 | General |
| Category: Endocrinology | ||||||
| 06/17/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.64 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/15/2021 | DEXCOM, INC. | DEXCOM G6 TRANSMITTER (Device) | Food and Beverage | In-kind items and services | $12.62 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/25/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.39 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/19/2021 | DEXCOM, INC. | DEXCOM G6 TRANSMITTER (Device) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/12/2021 | RECORDATI_RARE_DISEASES_INC. | — | Food and Beverage | Cash or cash equivalent | $19.49 | General |
| 04/23/2021 | Tandem Diabetes Care, Inc. | t-slim insulin pump (Device) | Food and Beverage | Cash or cash equivalent | $20.37 | General |
| Category: Endocrinology | ||||||
| 04/15/2021 | DEXCOM, INC. | DEXCOM G6 TRANSMITTER (Device) | Food and Beverage | In-kind items and services | $11.84 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/13/2021 | Lilly USA, LLC | BAQSIMI (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Diabetes | ||||||
| 04/08/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/09/2021 | AbbVie Inc. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $11.90 | General |
| Category: IMMUNOLOGY | ||||||
| 02/23/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: DIABETES | ||||||
| 02/16/2021 | Lilly USA, LLC | BAQSIMI (Drug) | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: Diabetes | ||||||
| 01/28/2021 | Ultragenyx Pharmaceutical Inc. | — | Food and Beverage | In-kind items and services | $22.71 | General |
| 01/19/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.56 | General |
| Category: DIABETES | ||||||
| 01/05/2021 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), STEGLUJAN | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/28/2020 | Xeris Pharmaceuticals, Inc. | GVOKE PFS (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: DIABETES | ||||||
| 12/08/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/24/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $12.47 | General |
| Category: DIABETES | ||||||
| 11/10/2020 | Lilly USA, LLC | BAQSIMI (Drug) | Food and Beverage | In-kind items and services | $15.30 | General |
| Category: Diabetes | ||||||
| 10/27/2020 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.51 | General |
| Category: DIABETES | ||||||
| 10/20/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/06/2020 | Lilly USA, LLC | BAQSIMI (Drug) | Food and Beverage | In-kind items and services | $13.52 | General |
| Category: Diabetes | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multicenter Study Evaluating the Efficacy and Safety of Selonsertib in Subjects with Moderate to Advanced Diabetic Kidney Disease | Gilead Sciences, Inc. | $1,197 | 18 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 16 | 35 | $3,591 | $2,299 |
| 2022 | 1 | 11 | 23 | $2,576 | $1,747 |
| 2021 | 6 | 121 | 142 | $18,070 | $7,124 |
| 2020 | 7 | 181 | 224 | $29,551 | $11,532 |
Total Patients
329
Total Services
424
Medicare Billing
$22,701
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 16 | 35 | $3,591 | $2,299 | 64.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 11 | 23 | $2,576 | $1,747 | 67.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 34 | 38 | $7,068 | $3,253 | 46.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 25 | 30 | $5,580 | $2,307 | 41.3% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 11 | 12 | $3,000 | $886.23 | 29.5% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 14 | 16 | $1,312 | $347.10 | 26.5% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 21 | 28 | $840.00 | $271.88 | 32.4% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2021 | 16 | 18 | $270.00 | $59.04 | 21.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 32 | 40 | $9,910 | $4,074 | 41.1% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 27 | 34 | $5,900 | $2,711 | 45.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 24 | 31 | $5,518 | $2,021 | 36.6% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 14 | 14 | $4,700 | $1,666 | 35.5% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2020 | 12 | 19 | $1,558 | $493.87 | 31.7% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 37 | 45 | $1,350 | $433.53 | 32.1% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2020 | 35 | 41 | $615.00 | $133.29 | 21.7% |
About Dr. Lynn Baru, MD
Dr. Lynn Baru, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Asheville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1972529055.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lynn Baru, MD has received a total of $8,522 in payments from pharmaceutical and medical device companies, with $313.88 received in 2021. These payments were reported across 226 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($3,295).
As a Medicare-enrolled provider, Baru has provided services to 329 Medicare beneficiaries, totaling 424 services with total Medicare billing of $22,701. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Asheville, NC
- Active Since 07/14/2006
- Last Updated 03/13/2018
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1972529055
Products in Payments
- Korlym (Drug) $4,278
- t-slim insulin pump (Device) $358.01
- FARXIGA (Drug) $314.67
- Repatha (Biological) $290.53
- Omnipod (Device) $262.81
- JARDIANCE (Drug) $181.52
- Victoza (Drug) $107.33
- Dexcom CGM (Device) $106.97
- FreeStyle Libre (Device) $100.56
- BAQSIMI (Drug) $97.81
- Saxenda (Drug) $93.08
- Tresiba (Drug) $86.49
- DEXCOM CGM (Device) $76.27
- HUMULIN (Drug) $69.09
- Ozempic (Drug) $64.48
- BD Nano (Device) $64.18
- Androgel (Drug) $43.73
- DEXCOM G6 TRANSMITTER (Device) $43.23
- NovoLog (Drug) $41.22
- NATPARA (Drug) $39.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Asheville
Richard Dodd, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $924,614
Endocrinology, Diabetes & Metabolism $924,614
Dr. Victor Marlar, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $815,366
Endocrinology, Diabetes & Metabolism $815,366
Dr. Wendy Lane, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $733,259
Endocrinology, Diabetes & Metabolism $733,259
Lauren Bernstein, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $280,697
Endocrinology, Diabetes & Metabolism $280,697
David Hester, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $23,730
Endocrinology, Diabetes & Metabolism $23,730
Stephen Weinrib, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $16,625
Endocrinology, Diabetes & Metabolism $16,625